﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>26</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>10</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Anti-N-methyl D-aspartate Receptor Encephalitis Following ChAdOx1 nCoV-19 Vaccination: A Case Report</ArticleTitle>
    <FirstPage>600</FirstPage>
    <LastPage>603</LastPage>
    <ELocationID EIdType="doi">10.34172/aim.2023.87</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Liyaghatdar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8804-5179</Identifier>
      </Author>
      <Author>
        <FirstName>Amirhosein</FirstName>
        <LastName>Rahimkhani</LastName>
      </Author>
      <Author>
        <FirstName>Amin</FirstName>
        <LastName>Liaghatdar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1407-7071</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/aim.2023.87</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>05</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <Abstract>As of December 2020, millions of people have been immunized using vaccines against SARS-CoV-2. A wide range of neurological adverse effects of SARS-CoV-2 vaccines have been reported so far. Here, we report a 23-year-old male who experienced psychiatric symptoms, loss of consciousness, language disintegration, and incontinency that happened 10 days after the first dosage of the COVID-19 AstraZeneca vaccine. Anti-NMDAR Encephalitis was diagnosed based on the results of the autoimmune panel. The patient responded to intravenous dexamethasone very well and experienced no other complications in 6 months of follow-up. Scientific reports of neurological side effects such as anti-NMDAR encephalitis after vaccination are necessary to optimize the safety and effectiveness of SARS-CoV-2 vaccines.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Anti-NMDAR encephalitis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Autoimmune encephalitis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Case report</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ChAdOx1 nCoV-19 vaccine</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>